Position in PRGO
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$216,561
-$107,044 QoQ
Shares Held
20,164
+66.5% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FOX RUN MANAGEMENT, L.L.C. holds $6,581,949 across 12 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
29,511 | $2,120,660 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
24,876 | $1,020,662 | |
| 3 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
44,817 | $804,913 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
139,728 | $688,859 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
18,952 | $466,408 | |
| 6 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
14,556 | $293,740 | |
| 7 | TLRY |
Tilray Brands, Inc.
|
63,112 | $283,372 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
16,028 | $277,444 |
All Filings in PRGO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $216,561 | 20,164 | Shares | Sole | 2026-05-12 | |
| 2025-06-30 | $323,605 | 12,111 | Shares | Sole | 2025-08-06 | |
| 2024-12-31 | $292,605 | 11,381 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $284,149 | 10,833 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $693,847 | 27,019 | Shares | Sole | 2024-08-13 | |
| 2023-09-30 | $207,515 | 6,495 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $316,481 | 9,322 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $476,389 | 13,281 | Shares | Sole | 2023-05-12 | |
| 2020-12-31 | $349,978 | 7,826 | Shares | Sole | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||